Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery

Pivotal study to evaluate next-generation synthetic small peptide technology (P-15) compared to autograft in most common spine procedure WESTMINSTER, Colo., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthob... Devices, Orthopaedic, FDA Cerapedics, orthobiologic, i-FACTOR, Peptide Enhanced Bone Graft
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news